Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

HKG:3613 Revenue

Beijing Tong Ren Tang Chinese Medicine Company had revenue of 601.89M HKD in the half year ending June 30, 2026, a decrease of -9.43%. This brings the company's total for the last twelve months to 1.35B, down -20.79% year-over-year. In the year 2025, Beijing Tong Ren Tang Chinese Medicine Company had annual revenue of 1.51B, down -6.10%. That makes Beijing Tong Ren Tang Chinese Medicine Company the 18,534th largest company in the world by revenue and 1,085th in Hong Kong.

• Revenue (ttm): 1.35B
• Revenue Growth: -20.79%
• P/S Ratio: 3.51
• Revenue / Employee: 1.77M
• Employees: 763
• Market Cap: 4.70B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Hong Kong 1.18B 63.6%
• Overseas 406.46M 22.0%
• Mainland China 266.10M 14.4%

By Geography

Chart

• Hong Kong 942.29M 62.3%
• Macao 223.27M 14.8%
• Chinese Mainland 164.87M 10.9%
• Australia 60.16M 4.0%
• Canada 43.21M 2.9%
• New Zealand 25.51M 1.7%
• Singapore 20.59M 1.4%
• Other 33.45M 2.2%

Fiscal year ended Dec 31, 2025 See the full HKG:3613 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.51B	-98.29M	-6.10%
Dec 31, 2024	1.61B	86.70M	5.69%
Dec 31, 2023	1.52B	-206.15M	-11.91%
Dec 31, 2022	1.73B	174.94M	11.24%
Dec 31, 2021	1.56B	240.81M	18.31%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error